Stocks and Investing Stocks and Investing
Tue, January 2, 2024
Fri, December 29, 2023
Thu, December 28, 2023
Wed, December 27, 2023
Tue, December 26, 2023
Fri, December 22, 2023
Thu, December 21, 2023
Wed, December 20, 2023

Li Watsek Reiterated (ASND) at Buy and Held Target at $152 on, Dec 20th, 2023


Published on 2024-10-28 08:05:41 - WOPRAI, Li Watsek
  Print publication without navigation


Li Watsek of Cantor Fitzgerald, Reiterated "Ascendis Pharma A/S" (ASND) at Buy and Held Target at $152 on, Dec 20th, 2023.

Li has made no other calls on ASND in the last 4 months.



There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 1 agrees with Li's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $116 on, Thursday, November 9th, 2023


This is the rating of the analyst that currently disagrees with Li


  • Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $149 on, Tuesday, December 19th, 2023